Showing all 5 results
Skin Cancer Leukopak
LeukoCore™ Skin Cancer Leukopak products contain concentrated immune cells from donors with clinically confirmed skin cancer, collected via apheresis. Ideal for high-yield studies on tumor immunology, T cell responses, and immune profiling in cutaneous malignancies such as melanoma and non-melanoma skin cancers.
Skin Cancer PBMC
Skin Cancer PBMC samples are isolated from donors with clinically confirmed Skin Cancer. Ideal for studying tumor-immune interactions, T cell exhaustion, and immune checkpoint responses across skin cancer subtypes such as melanoma, basal cell carcinoma, and squamous cell carcinoma.
Skin Cancer Plasma
Skin Cancer Plasma samples are collected from donors diagnosed with Skin Cancer. Suitable for analyzing circulating tumor DNA (ctDNA), cytokines, and immunomodulatory biomarkers associated with disease activity and treatment response.
Skin Cancer Serum
Skin Cancer Human Serum samples are derived from donors with confirmed Skin Cancer. Useful for detecting tumor-associated antigens, immune mediators, and systemic markers of inflammation and metastasis.
Skin Cancer Whole Blood
Skin Cancer Whole Blood samples are obtained from donors with clinically diagnosed Skin Cancer. Valuable for transcriptomic and genomic profiling, immune cell analysis, and identification of molecular drivers of tumor progression and therapy resistance.